Immunotherapy in older adults with cancer – Rethinking the toxicity of treatment
Talk 1: Toxicity of immunotherapy in older adults – the scale of the problem
Talk 2: What is the impact of immunotherapy toxicity on frail older adults?
Talk 3: Toxicity management – What is the impact of corticosteroids on older adults with cancer?
Talk 4: Is it time for a paradigm shift? What is the role of DMARds in toxicity management?
Hourly Schedule
MDT Maximal treatment vs descalation Ovarian cancer and Gastric cancer
- 11:00 - 11:30
- Case = ‘Vulnerable’ patient (not fit, not very frail) with new diagnosis of ovarian cancer
- 11:30 - 12:00
- Case = ‘vulnerable’ patient (not fit, not very frail) with new gastric cancer
Leave A Comment
You must be logged in to post a comment.